跳至主要内容
临床试验/NCT01972061
NCT01972061终止不适用

Foot/Hand Neuromodulation for Overactive Bladder (OAB)

Christopher J Chermansky, MD2 个研究点 分布在 1 个国家目标入组 44 人开始时间: 2014年3月最近更新:
适应症

试验速览

阶段
不适用
状态
终止
发起方
入组人数
44
试验地点
2
主要终点
Number of Urinary Incontinence Episodes Per Day

研究概览

简要总结

The purpose of this study is to determine if electrical stimulation of the foot is effective in the treatment of overactive bladder conditions.

详细描述

Foot neuromodulation is designed to treat OAB conditions by electrically stimulating the somatic afferent nerves in the foot using skin surface electrodes. The foot stimulation is non-invasive, can be performed at home, and has no adverse effects. Foot neuromodulation therapy will likely be accepted by more patients and have the potential to make a broader impact on the improvement of OAB conditions.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 18 year old men and women and older
  • Currently having overactive bladder (OAB) symptoms, i.e. urgency, frequency, or incontinence
  • No evidence of neurological disorder or urinary tract infection, i.e. clinically diagnosed as idiopathic OAB

排除标准

  • Pregnant women in their late pregnancy phase will be excluded because the increasing size of the baby/uterus may cause overactive bladder.
  • Patients with implanted electrical stimulators such as pacemaker will be excluded for potential interference with the TENS stimulator.
  • Patients who are allergic to Cipro or Bactrim will be excluded from the CMG study.

结局指标

主要结局

Number of Urinary Incontinence Episodes Per Day

时间窗: Week 1, Week 2, Week 3

Participants kept a daily voiding diary during week 1 (baseline), week 2 (foot stimulation), and week 3 (post foot stimulation). The average number per day urinary incontinence episodes was calculated for week 1 and week 2 for each subject.

次要结局

  • Number of Urinary Urgency Episodes Per Day(Week 1, Week 2, Week 3)

研究者

发起方
Christopher J Chermansky, MD
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Christopher J Chermansky, MD

Assistant Professor of Urology

University of Pittsburgh

研究点 (2)

Loading locations...

相似试验